Exploring Generalisations for Sustainability Assessment in Medicine Manufacturing Networks by Settanni, Ettore et al.
1 
Exploring Generalisations for Sustainability 
Assessment in Medicine Manufacturing Networks 
Ettore Settanni (E.Settanni@eng.cam.ac.uk)  
Institute for Manufacturing, University of Cambridge, Cambridge, UK 
Jagjit Singh Srai 
Institute for Manufacturing, University of Cambridge, Cambridge, UK 
Ekaterina Yatskovskaya 
Institute for Manufacturing, University of Cambridge, Cambridge, UK 
Tomás S. Harrington 
Institute for Manufacturing, University of Cambridge, Cambridge, UK 
Abstract 
Generalisations or ‘rules of thumb’ are widely used in industry to make initial assessments 
on the sustainability impacts of products. This paper re-examines the princip les 
underpinning these generalisations in assessing the environmental impacts of medicine 
manufacturing network configurations. Each principle is illustrated through the 
application of selected methods, tools, and data using an exemplar case of a major non-
proprietary analgesic. The findings identify the kind of generalised knowledge claims that 
are possible using alternative approaches, and which methodological issues may arise. 
Keywords: generalisations, sustainable supply chains, pharmaceuticals 
Introduction 
Simplifications based on some degree of generalisation are commonly employed in an 
effort to capture the environmental impact of an entire supply chain without imposing 
daunting data collection requirements on each chain member (Pagell and Shevchenko, 
2014). For example, the NHS England attributing 21% of its carbon footprint to the 
procurement of pharmaceuticals is partly based on generalised relationships between 
certain characteristics of synthesising an Active Pharmaceutical Ingredient (API) and the 
amount of greenhouse gases released (Penny et al., 2015). 
Generalisations across pharmaceutical product categories, if discovered, are believed 
to greatly simplify the otherwise challenging task of assessing environmenta l 
sustainability in medicine manufacturing networks – see, for example Hartmann (2015); 
Soete et al. (2014). While there is no single approach to generalisations discovery, these 
are typically proposed as ‘quicker’ and ‘simpler’ – and hence more desirable – 
alternatives to standardised, analytical approaches such as Life Cycle Assessment (LCA), 
which often provide complementary insights for the purposes of mathematical Supply 
Network Design – see Eskandarpour et al. (2015) for an overview. 
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This paper aims to systematically address the emerging need for simplification in 
assessing the ‘end-to-end’ environmental repercussions of current and future medicine 
manufacturing network configurations. It does so by 1) identifying a set of generalisa t ion 
principles underpinning the approaches more commonly used in the academic literature; 
and 2) illustrating each principle through the application of selected methods, tools, and 
data to the same exemplar case based on a large-selling non-proprietary analgesic. These 
points are elaborated, in the ‘materials and methods’, and ‘findings’ sections. The 
‘discussion’ section outlines the key contribution of the paper, which is the simultaneous 
exploration of approaches that are often seen as mutually exclusive, to answer questions 
such as: what kind of generalised knowledge claim are supported? Which methodologica l 
tensions may arise? Which synergies can be exploited? The paper closes by pinpoint ing 
research limitations, and providing directions for future work. 
 
Materials and methods 
The term ‘generalisations’ denotes knowledge claims, gathered under certain 
methodological conditions, which exhibit properties that make them applicable to more 
than one situation (Metcalfe, 2005). Table 1 shows how these properties vary depending 
on the epistemological stance taken, and provides specific examples from sustainab le 
supply chain research with a focus on the pharmaceutical sector. 
The number of approaches and tools available within each epistemology is potentially 
vast due the inter-disciplinary nature of investigating sustainability-related aspects in 
supply chain network design (Haskins, 2006). To keep the focus, the examples reported 
in Table 1 are limited to approaches and tools that are relevant at the interface between 
the following adjacent but distinct fields: Supply chain network design (SCND), 
simplified/streamlined Life Cycle Assessment (LCA), and Hot Spot Analysis (HSA). 
While the application of LCA to support SCND is widespread (see e.g., Eskandarpour et 
al., 2015), the relationship between LCA and HSA is still debated (UNEP-SETAC, 2014), 
and the use of the latter in SCND is relatively unexplored (Liu and Srai, 2011).  
Within the chosen scope, the analytical approaches to generalisation identified by 
synthesis of the relevant literature (not reported here in full due to space constraints), 
classified, and then put to use on an example centred on paracetamol (also known as 
acetaminophen and by its chemical name, N- (4- hydroxyphenyl) acetamide), one of the 
largest-selling non-proprietary drugs worldwide and the most widely used and prescribed 
first line analgesic in UK. 
Table 1 – Views on, and exemplar of generalisations  
Views on generalisation (based on 
Metcalfe, 2005) 
Example application to sustainability evaluation in 
pharmaceutical supply chains 
Epistemology Research agenda Methodology Data collection 
method 
Reference 
Scientific Pursue of general 
truth by induction and 
falsification 
Statistical 
analysis of 
quantitative data 
Observations; 
Experiments 
Soete et al. (2014) 
Systems 
thinking 
See something in 
terms of boundaries, 
purpose, connectivity 
Diagrammatic 
visualisation; 
simultaneous 
equations 
Documents; 
Observations 
Jiménez-González 
et al. (2010) 
Interpretative Generate critical 
heuristic and rules of 
thumb for future 
action 
Survey; Case 
study research; 
Mixed methods 
Interviews; 
Questionnaire 
Hartmann (2015) 
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Although without reference to the pharmaceutical sector, the application of different 
types of analysis to a single hypothetical example instead of discussing each model 
separately has been previously used to evaluate differences and similarities in a practical 
way (Bouman et al., 2000). 
 
Findings 
The most common generalisation principles found in the literature on sustainable supply 
chains of pharmaceutical products can be summarised as shown in Fig. 1, and as described 
below:  
• First principles (FP): generalise the understanding of detailed causal mechanisms. A 
system thinking epistemological stance is typically taken. Representative approaches 
(off-the-shelf tools) include: LCA (IfU Hamburg Umberto NXT Universal, with 
Ecoinvent database); flowsheet simulation (Intelligen SuperPro Designer); 
• Statistical inference (SI): identifies associative relationships based on a track record 
of evidence, taking a scientific epistemological stance. Representative approaches 
(tools) include: data visualisation and descriptive statistics (Tableau); multivar ia te 
regression and supervised segmentation (specialised packages for the statistica l 
programming language R (R Development Core Team, 2008); Artificial Intelligence 
(EstiMol); 
• Subjective judgment (SJ), based on individual knowledge elicitation, generalises the 
relative importance of aspects that are relevant for taking a certain decision. Assumes 
an interpretative epistemological stance. Representative approaches may vary, but 
mostly employ scoring systems whereby evidence is gathered from literature/case 
study (for an overview, see UNEP-SETAC, 2014). 
The results obtained from the application of the selected approaches are illustrated in 
dedicated sub-sections below. 
 
 
 
 
Figure 1 – Generalisation principles  
 
First 
principles
Statistical 
inference
Subjective 
judgment
‘Cookbook’ recipes for unit operations:
• company-independent, representative manufacturing 
technique (e.g., Ecoinvent data), 
• sector-level approximations (e.g., ’hybrid’ approaches, 
macroeconomic data)
Association between explanatory and 
target variables from empirical data (e.g., 
company-specific)
Elicit and combine expert knowledge through 
Likert-type scoring system
Common data layout, 
computational principles,
practice
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Evaluation of the exemplar case using First Principles (FP) 
Although paracetamol is a well-known pharmaceutical product, the authors could not 
easily identify references in the public domain that provided a sufficiently transparent 
account of the material flows ‘end-to-end’, across the manufacturing system of interest. 
A hypothetical system of unit operations for the manufacture of paracetamol was 
therefore derived according to FP generalisations from data available in the public 
domain. The steps followed to this purpose are summarised below and illustrated 
schematically in Fig. 2 (more details are provided elsewhere, see Settanni, 2016): 
• The boundaries of the foreground system span from the manufacture the Active 
Pharmaceutical Ingredient (API) to the manufacture of a solid dosage form. 
• The scope of the analysis was limited to a subset of manufacturing operations, and 
the associated material and energy flows, although the operations associated with 
transportation and packaging, were excluded at this stage.  
• In the absence of site-level data that are typically available for specific businesses, it 
was assumed that the manufacturing of the API takes place in India, where most 
suppliers of paracetamol into the UK are located, according to current site 
authorisation data (http://eudragmdp.ema.europa.eu/).  
• Several routes for the synthesis of the API, and alternative technologies to 
manufacture the dosage forms (mainly batch vs flow chemistry) are available – see, 
respectively, Joncour (2014); Soete et al., (2013). The gathered data refer to one of 
the routes most exploited commercially, which seems representative of the prevailing 
manufacturing technology in key manufacturing countries such as India. 
• Molar mass balances for the reactive and non-reactive systems involved in most 
manufacturing steps were based on literature and patent search. Public domain data 
on typical batch size and manufacturing capacity at industrial scale are sparse. 
• The amount and composition of the material flows between the manufactur ing 
operations at the relevant scale were estimated from the data thus gathered, using a 
combination of manual computations and computer-aided process simulation. 
• The estimated flows were imported in an LCA tool, where the foreground system 
was expanded, whenever possible, and the Life Cycle Inventory and Impact 
Assessment calculations were carried out. Expansion of the foreground system 
implies the retrieval, by database search, and addition of ‘generic’ unit operations 
which are assumed to be representative of all the activities taking place upstream. 
A variety of impact categories and impact assessment methods are available, the 
discussion of which is beyond the scope of this paper. For illustrative purposes Fig. 2b 
shows the contribution of the unit processes mapped in Fig. 2a across five impact 
categories quantified according with two assessment methods. In the remainder of this 
paper, the focus is placed on the impact category ‘Global Warming Potential’ (GWP), 
expressed as kgCO2-eq. (here, computed according to the IPCC methodology using 
Umberto NXT). A focus on GWP is common in estimating a product ‘carbon footprint’. 
According the FP generalisation of the manufacturing system of interest here, the 
estimated carbon footprint associated with 1kg of API is circa 78 kgCO2-eq (or circa 68 
kgCO2-eq per kg of finished product, coated tablets), 57% of which is attributed to the 
unit processes included in the primary manufacturing phase, whereas 43% represents 
‘upstream’ impacts which are embedded in the procured materials. The breakdown in Fig. 
2b reveals that the main contributors are the treatment of hazardous waste – namely iron 
oxide sludge generated during the reduction of p-nitrophenol into p-aminophenol – and 
the manufacture of the main starting material, p-chloronitrobenzene, both of which are 
characteristic features of the synthesis route assumed upfront for the API. 
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Evaluation of the exemplar case using statistical inference (SI) 
The use of statistical inference, or ‘parametric’ estimation is based on the assumption that 
the environmental impact of a product (e.g., its carbon footprint) is a dependant variable 
that has the propensity to be related statistically to a set of potentially informative 
attributes of such product. Hence, generalisations developed on the basis of the SI 
principle are typically established in the form of associative relationships between some 
dependant variable (or ‘target’ to be predicted) and some knowable attributes that relate 
with it (parameters), for which previous observations exist. Approaches that apply this 
principle typically favour the speed of results over good explanation facilities, as opposed 
to the FP case examined in the previous sub-section. 
 
(a) 
 
(b) 
Figure 2 – (a) Hypothetical manufacturing network for a non-proprietary analgesic based on 
FP generalisations (b) Impact assessment across five categories 
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Specific applications of SI to pharmaceutical products use linear and non-linear 
regression to establish generalisations in the form of associative relationships between 
variables that may be chosen differently across studies. Example include the estimate of 
an APIs’ carbon footprint form such parameters as the amount of organic solvent used, 
as well as process parameters like molar efficiency and synthesis time (Soete et al., 2014). 
Industry-wide initiatives include a tool that apply SI for the quick approximation of the 
footprint of pharmaceutical products developed by the Association of British 
Pharmaceutical Industry (ABPI) in collaboration with the Carbon Trust, based on data 
contributed by major industrial players (Carbon Trust, 2013). 
To apply the SI principle to the case exemplar considered here, an excerpt was obtained 
under confidentiality agreement from a broader dataset underpinning the ABPI tool. Due 
to the nature of the data excerpt, only the primary manufacture of the paracetamol API 
could be assessed. The data was preliminary assessed through descriptive statistics to 
characterise the values recorded for each variable – three continuous, two categorical. By 
segmenting the carbon footprint values reported across the anonymised products it 
appeared that larger scales exhibit less variability and systematically lower emissions 
(Fig. 3a). Each continuous variable was tested for normality, and the strength and 
direction of its linear association with the other variables was assessed. For the sake of 
example, Fig. 3b shows the normality test, the coefficient of correlation, coefficient of 
determination (R2), and p-value of the test of significance of the overall regression 
 
(a) (b) 
 
(c) 
Figure 3 – Analysis of carbon footprint data and product attributed across for multiple APIs 
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between the variable ‘carbon footprint’, the log of the production scale, and the number 
of synthesis steps).  
Since no clear-cut linear association between the variables emerged from the data, a 
supervised segmentation approach was applied to automate the process of ranking the 
explanatory variables according with their ability to predict the value of a modified target 
– whether the carbon footprint would be less than 900 kgCO2-eq per kg of API. The main 
difference being that, unlike regression, segmentation aims to predict whether something 
will happen rather than ‘to what extent’ it will happen (Provost and Fawcett, 2013). A 
tree-structure model was generated using the rpart package for the statistical software R 
(shown on the leftmost side of Fig. 3c). The model demonstrates that most APIs with a 
carbon footprint above 900 kgCO2-eq per kg of product (crosses on the rightmost part of 
Fig. 3c) are characterised by manufacturing capacity of less than 12 ton per annum (tpa) 
and a number of steps above 3.5. In principle, the exemplar case of paracetamol API 
modelled according to FP falls into this category, since a small scale was hypothesised 
for the sake of simplicity. However, the result obtained from a FP environmental impact 
assessment of the GWP associated with the API was significantly below the value 
expected applying SI based on past observations. 
While regression requires process and product-related parameters as an input, ‘black 
box’ tools such as EstiMoL explore relationships between the molecular structure of the 
API of interest and target variables such as GWP (Wernet et al., 2010). In the case of 
paracetamol, the EstiMol tool produces an estimate of 5.965 kgCO2-eq (± 6.491). 
 
Evaluation of the exemplar case using subjective judgment (SJ) 
An alternative to estimating the ‘magnitude’ of the environmental impact of 
manufacturing pharmaceutical products is to express the relative importance of the 
contribution to that impact from the relevant elements of the supply chain as scores 
(ordinal data), typically obtained by eliciting expert judgment. For example, Liu and Srai 
(2011) elicit subjective judgment to evaluate the maturity of an organisation’s ‘green’ 
capabilities in product design, procurement, production, logistics, and reverse logist ics, 
thus discovering possible generalisations based on a number of business cases. This 
approach has been applied to multiple case studies in the pharmaceutical supply chain 
(Hartmann, 2015). 
Similarly, the Wuppertal Institute’s Sustainability Hot Spot Analysis (UNEP-SETAC, 
2014) also employs evidence gathered in the form of ordinal data, either from literature 
or through experts interviews, to score the resource intensities in a two-step process: first, 
within each life-cycle stage, across groups of resources; then between each life-cyc le 
stage an evaluation of each stage of a product life cycle in relation to the other stages; 
finally, multiplying the scores obtained in the previous steps. However, the scoring in the 
second step is not carried out as a pairwise comparison, and the final step does not provide 
explicit computational devices to reduce subjective bias.  
To address these limitations, a variation of Wuppertal’s three-step approach is 
suggested, based on an application of the principles of the Analytical Hierarchy Process 
- AHP (Saaty, 1990), and applied to the paracetamol example as follows (Fig. 4): 
• Step 1: four features (direct emissions and emissions embedded in resources, 
energy, and waste), are scored against each other in terms of their relative 
importance. This is accomplished in a pairwise criterion comparison matrix; 
• Step 2: three aggregated life cycle stages of the pharmaceutical product (API and, 
dosage form manufacture; packaging) are scored against each other with respect to 
each feature. This is accomplished in a number of pairwise options comparison 
matrices. 
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• Step 3: The relative importance (ranking) of each life cycle stage considering all 
the resource groups simultaneously is produced by means of AHP matrix algebra 
The scores in the example are for illustrative purposes only, and based on evidence 
from limited literature available on paracetamol (Hartmann, 2015; Soete et al., 2013), as 
well as the researcher’s experience. The eigenvalues and eigenvectors required to obtain 
the ranking according to the matrix equation shown in Fig. 4 were computed using 
MATLAB®. The API manufacturing stage ranks highest – which aligns with the results 
of the assessment from FP previously carried out. 
 
Discussion 
In the previous section, three generalisation principles were identified (FP, SI and SJ), 
and illustrated by applying representative approaches and tools to the same streamlined 
example based on the manufacture of paracetamol API, and a solid dosage form. With 
the exception of SI, the application of each approach was carried out using, whenever 
possible, publicly available data related to the hypothetical case. The findings form such 
an application are summarised in Tab. 2, and are discussed below. 
Generalisations based on FP mostly concern individual unit operations, and provide 
the most detailed insights in terms of environmental burden attributed to individual unit 
operations/product life cycle phases. However, in the absence of real-life industry data, 
the results generated by simulation can be very sensitive to the assumptions made upfront. 
For example, in the simplified case considered here, the unit operations model is not 
optimally designed to recover waste flows such as wastewater (e.g., filtrate) and the iron 
sludge generated in the reduction stage. While the presence of significant effluents at 
various stages of API manufacturing is in line with some industry outlooks, the presence 
of non-optimised water flows at the plant level may raise issues, especially in water 
stressed areas such as India. Also, the estimates obtained using this approach appear to 
be very sensitive to the assumptions regarding the amount of fresh and recirculated heat 
exchange media such as the refrigerant assumedly used during crystallisation. Finally, 
most materials used in the secondary manufacturing were difficult to retrieve while 
expanding the model, and were therefore cut-off. 
Approaches based on the SI and SJ generalisation principles are typically meant to 
overcome the complexities of FP by simplification. SI, in particular, aims to generalise 
 
 
Figure 4 – Application of AHP in the subjective judgment-based Hotspot Analysis of 
paracetamol  
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the relationship between some informative attributes of a manufacturing system and some 
‘target’ variable. However, as demonstrated by the application to the exemplar case, a 
sufficiently track record of products assessed ‘end-to-end’, most likely from FP, is needed 
to provide the necessary data for SI to apply. Even in when data and free tools are 
available (for example, by the pharmaceutical industry associations as in the UK), there 
seems to be a large variation between the values obtained from FP and the values inferred. 
Since the underpinning data (e.g., carbon footprint of a product) are the result of 
computations rather than direct observation/measurement, legitimate concerns arise 
regarding whether and to what extent each data point contributed by different firms and 
then employed for the purposes of SI is computed consistently – e.g., following the same 
principles, and using similar tools and computational procedures. 
Finally, approaches based on the SJ principle, such as scoring, may be appealing when 
the emphasis is on providing heuristics for taking action along a supply chain rather than 
estimating a metric. In this paper, SJ was applied to synthesise evidence from the 
literature. Often, such evidence is limited for specific pharmaceutical products, and 
difficult to align, thus making a meaningful comparison difficult. It was also observed 
that current SJ approaches may benefit from techniques that help reduce subjective bias 
by using rigorous computational devices to combine scores – as, for example, AHP. 
 
Conclusion 
This paper presented a first attempt to identify a set of generalisation princip les 
underpinning the approaches more commonly used to make knowledge claims about the 
environmental repercussions of current and future medicine manufacturing network 
configurations. Each principle was illustrated by application of selected methods, tools, 
and data to the same exemplar case based on a large-selling non-proprietary analgesic. 
While most works treat these approaches and the underpinning principles as mutua lly 
exclusive, the application of different types of analysis to a single hypothetical example 
has proven useful to evaluate differences and similarities in a practical way.  
This paper has several limitations, including assumptions used in building a simula t ion 
model of the manufacturing operations from first principles in the absence of industry-
specific information. Also, only a limited number of approaches and tools available have 
been considered. Despite its limitations, the findings of this research help to address, both 
conceptually and through example applications, the challenge to capture the 
environmental impact of the entire supply chain, without imposing daunting data 
collection campaigns on each chain members.  
To endorse a truly ‘end-to-end’ perspective, it is necessary to consider the 
pharmaceutical product ‘in use’. A more appropriate definition of the functional unit, than 
one unit mass of API or dosage form is necessary to this purpose. Future work should 
expand the boundaries of the analysis downstream to capture the complexities of the 
Table 2 – Summary of findings with regards to the GWP impact category 
  Generalisation principle applied 
  FP SI SJ 
  Value Unit* Value Unit* Value Unit 
Raw materials** 32.9 kg/CO2-e NA  NA  
API manufacture 44.5 kg/CO2-e >900 kg/CO2-e 0.663 - 
Secondary manufacture 0.06 kg/CO2-e NA  0.259 - 
Packing*** 0.91 kg/CO2-e NA  0.078 - 
*Relative to 1 kg of crude paracetamol (API); **For the manufacture of the API;***No end-of-life scenario. 
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medicine distribution and utilisation systems, to support the assessment of more patient-
centric and distributed medicine networks. 
 
Funding acknowledgment  
Support from the Advanced Manufacturing Supply Chain Initiative (Grant No. 35708-233529, ReMediES 
– Reconfiguring Medicines End-to-end supply), and the EPSRC (Grant No. EP/I033459/1, Centre for 
Innovative Manufacturing in Continuous Manufacturing and Crystallisation; and Grant No. 
EP/K02888X/1, Engineering Driven Sustainable Supply Networks-A UK/India Collaborative Study) is 
gratefully acknowledged. 
 
References 
Bouman, M., Heijungs, R., van der Voet, Ester, van den Bergh, Jeroen C. J. M and Huppes, G. (2000), 
“Material flows and economic models: an analytical comparison of SFA, LCA and partial equilibrium 
models”, Ecological Economics, Vol. 32 No. 2, pp. 195–216. 
Carbon Trust (2013), New carbon footprint tool launched to calculate the carbon footprint of 
pharmaceutical products [http://www.europeanpharmaceuticalreview.com/20994/news/] 
Eskandarpour, M., Dejax, P., Miemczyk, J. and Péton, O. (2015), “Sustainable supply chain network 
design: An optimization-oriented review”, Omega, Vol. 54 No. 0, pp. 11–32. 
Hartmann, C. (2015), “Impact of environmental sustainability on the configuration of supply chains in the 
pharmaceutical industry”, Master of Philosophy, Institute for Manufacturing, University of Cambridge, 
Cambridge, UK, 2015. 
Haskins, C. (2006), “Application of Systems Engineering and Other Disciplines to the Design of a 
Sustainable Supply Chain”, 4th Annual Conference on System Engineering, April 7-8, Los Angeles. 
Jiménez-González, C., Ponder, C.S., Hannah, R.E. and Hagan, J.R. (2010), “Designing a Sustainable 
Pharmaceutical Industry: The Role of Chemical Engineers”, in am Ende, David J. (Ed.), Chemical 
Engineering in the Pharmaceutical Industry, John Wiley & Sons, Inc, pp. 57–65. 
Joncour, R., Duguet, N., Metay, E., Ferreira, A. and Lemaire, M. (2014), “Amidation of phenol derivatives: 
a direct synthesis of paracetamol (acetaminophen) from hydroquinone”, Green Chem, Vol. 16 No. 6, 
pp. 2997–3002. 
Liu, Y. and Srai, J.S. (2011), “Sustainable Supply Chain Configuration: Proposing a Hot Spot Analysis 
Methodology”, Proceedings of the International Conference on Materials Science, Metal & 
Manufacturing, 12-13 December, Singapore. 
Metcalfe, M. (2005), “Generalisation: Learning Across Epistemologies”, Forum Qualitative Social 
Research, Vol. 6 No. 1. 
Pagell, M. and Shevchenko, A. (2014), “Why Research in Sustainable Supply Chain Management Should 
Have no Future”, Journal of Supply Chain Management, Vol. 50 No. 1, pp. 44–55. 
Penny, T., Collins, M., Whiting, A. and Aumônier, S. (2015), Care Pathways: Guidance on Appraising 
Sustainability. [http://www.sduhealth.org.uk] 
Provost, F. and Fawcett, T. (2013), Data science for business, O'Reilly, Sebastopol, CA. 
R Development Core Team (2008), R: A Language and Environment for Statistical Computing, Vienna, 
Austria, available at: http://www.R-project.org. 
Saaty, T.L. (1990), “Decision making by the analytic hierarchy process: Theory and applications - How to 
make a decision: The analytic hierarchy process”, European Journal of Operational Research, Vol. 48 
No. 1, pp. 9–26. 
Settanni, E. (2016), Estimating material balances in the manufacture of crude paracetamol. Unpublished 
report. Institute for Manufacturing, University of Cambridge. 
Soete, W. de, Debaveye, S., Meester, S. de, van der Vorst, G., Aelterman, W., Heirman, B., Cappuyns, P. 
and Dewulf, J. (2014), “Environmental sustainability assessments of pharmaceuticals: an emerging  
need for simplification in life cycle assessments”, Environmental science & technology, Vol. 48 
No. 20, pp. 12247–12255. 
Soete, W. de, Dewulf, J., Cappuyns, P., van der Vorst, G., Heirman, B., Aelterman, W., Schoeters, K. and 
van Langenhove, H. (2013), “Exergetic sustainability assessment of batch versus continuous wet 
granulation based pharmaceutical tablet manufacturing: a cohesive analysis at three different levels”, 
Green Chem, Vol. 15 No. 11, pp. 3039–3048. 
UNEP-SETAC (2014), Hotspots Analysis: mapping of existing methodologies, tools and guidance and 
initial recommendations for the development of global guidance. [http://www.lifecycleinitiative.org/] 
Wernet, G., Papadokonstantakis, S., Hellweg, S. and Hungerbuhler, K. (2009), “Bridging data gaps in 
environmental assessments: Modeling impacts of fine and basic chemical production”, Green Chem, 
Vol. 11 No. 11, pp. 1826–1831. 
View publication stats
